Mundipharma International Limited's Commitment to Accelerated Business Growth Supported by Appointment of Paul Medeiros to Head its Corporate and Business Development
3/14/2012 6:45:44 AM
More...
|
Horizon Pharma, Inc. Enters Into Exclusive Agreement With Mundipharma International Limited for Commercialization of LODOTRA(R) (Modified-Release Prednisone) in Latin America
3/7/2012 8:49:50 AM
More...
|
Infinity Pharmaceuticals Inc. (INFI) Gets $50 Million More in Mundipharma International Limited Deal
11/29/2011 7:02:20 AM
More...
|
Mundipharma International Limited Release: New Research Shows Chronic Pain is not Being Adequately Measured[1]
10/10/2011 11:35:28 AM
More...
|
Infinity Pharmaceuticals Inc. (INFI) and Mundipharma International Limited Extend Global Strategic Alliance; Mundipharma Commits to Providing Up to $110 Million for 2012
12/13/2010 11:55:40 AM
More...
|
Infinity Pharmaceuticals Inc. (INFI) Announces That Purdue Pharmaceutical Products L.P. and Mundipharma International Limited Exercise Rights to Develop and Commercialize Infinity's FAAH Pain Program Worldwide
10/26/2010 8:56:25 AM
More...
|
Mundipharma International Limited: Levact(R) (bendamustine) Recommended for Approval in Europe for Treating Blood Cancers
3/19/2010 10:44:57 AM
More...
|
Novelos Therapeutics, Inc. and Mundipharma International Limited Sign Exclusive Collaboration Agreement in Europe and Japan; Deal Potentially Worth $95 Million
2/12/2009 7:43:11 AM
More...
|
Infinity Pharmaceuticals, Inc. Announces Global Strategic Alliance With Purdue Pharmaceuticals L.P. and Mundipharma International Limited Encompassing Infinity's Early Clinical and Discovery Programs; Infinity to Receive Up to $75M Equity Investment, Access to $50M Line of Credit, and Significant R&D Funding Over Multiple Years
11/20/2008 8:50:59 AM
More...
|
Sosei Co., Ltd. Announces Agreement With Mundipharma International Limited For Ad 923
6/27/2006 11:10:28 AM
More...
|
|